-
Hypoactive ****ual
desire disorder (HSDD), hypo****uality, or
inhibited ****ual
desire (ISD) is
sometimes considered a ****ual dysfunction, and is characterized...
-
disturbances including changes in
psychomotor activity (e.g., hyperactive,
hypoactive, or
mixed level of activity),
disrupted sleep-wake cycle,
emotional disturbances...
- first-in-class medication.
Bremelanotide is used for the
treatment of
generalized hypoactive ****ual
desire disorder (HSDD) in
premenopausal women.
Specifically it...
- a
medication approved for the
treatment of pre-menopausal
women with
hypoactive ****ual
desire disorder (HSDD). The
medication improves ****ual desire,...
-
pleasure (see anhedonia) from an ****. It is
thought to be a
variant of
hypoactive ****ual
desire disorder. Normally,
humans feel
pleasure from an ****;...
-
validated instrument developed to
specifically ****ess the
severity of
hypoactive ****ual
desire disorder and
responses to
treatment for the
disorder in...
- condition) 625.8
Female hypoactive ****ual
desire disorder due to ... [indicate the
general medical condition] 608.89 Male
hypoactive ****ual
desire disorder...
- following: Type 1 vWD:
hypoactive agglutination occurs (consistent with
ristocetin cofactor ****ay results) Type 2A vWD:
hypoactive agglutination occurs...
- drug-s****ing behaviour.
Clayton AH (July 2010). "The
pathophysiology of
hypoactive ****ual
desire disorder in women". Int J
Gynaecol Obstet. 110 (1): 7–11...
-
United States not as a
photoprotective agent, but for the
treatment of
hypoactive ****ual
desire disorder in
premenopausal women. All of
these drugs have...
